ArticleHerald of the Russian Academy of Sciences2022
Safe Use of Genetic Technologies.
Article in Herald of the Russian Academy of Sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prospects and problems of the development of modern genetic technologies are analyzed, and pressing issues of updating the regulatory framework for the safe use of their products are posed in this article, which is based on the materials of reports at the RAS Presidium meeting on December 7, 2021. At the end of 2018, by Presidential Decree no. 680 On the Development of Genetic Technologies in the Russian Federation, this R&D area was declared a priority. According to the authors, to expand genetic technologies in Russia, it is necessary to change the concept of their legal regulation and to bring the legislative norms in line with the current level of the development of science in this area, including the adjustment of the genetic engineering nomenclature.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.